{"database": "openregs", "table": "documents", "is_view": false, "human_description_en": "where docket_id = \"FDA-2020-D-1137\" sorted by posted_date descending", "rows": [["FDA-2020-D-1137-0120", "FDA", "FDA-2020-D-1137", "Development and Licensure of Vaccines To Prevent COVID\u201319; Guidance for Industry; Availability", "Notice", "Notice of Availability", "2023-10-20T04:00:00Z", 2023, 10, "2023-10-20T04:00:00Z", null, "2023-10-20T15:14:26Z", "2023-23162", 0, 0, "09000064861132e0"], ["FDA-2020-D-1137-0121", "FDA", "FDA-2020-D-1137", "Development and Licensure of Vaccines to Prevent COVID-19 Guidance for Industry", "Other", "Guidance", "2023-10-20T04:00:00Z", 2023, 10, "2023-10-20T04:00:00Z", null, "2025-08-29T09:00:27Z", null, 1, 0, "0900006486114f60"], ["FDA-2020-D-1137-0119", "FDA", "FDA-2020-D-1137", "Guidance Documents Related to Coronavirus Disease 2019 (COVID\u201319)", "Notice", "General Notice", "2023-03-13T04:00:00Z", 2023, 3, "2023-03-13T04:00:00Z", null, "2023-03-13T14:30:04Z", "2023-05094", 0, 0, "090000648579c133"], ["FDA-2020-D-1137-0118", "FDA", "FDA-2020-D-1137", "Guidance Documents Related to\nCoronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2022-04-22T04:00:00Z", 2022, 4, "2022-04-22T04:00:00Z", null, "2022-04-25T03:50:54Z", "2022-08564", 0, 0, "090000648502d74a"], ["FDA-2020-D-1137-0114", "FDA", "FDA-2020-D-1137", "Emergency Use Authorization for Vaccines to Prevent COVID-19; Guidance for Industry", "Other", "Guidance", "2022-03-31T04:00:00Z", 2022, 3, "2022-03-31T04:00:00Z", null, "2022-04-25T03:47:04Z", null, 0, 0, "0900006484ff005c"], ["FDA-2020-D-1137-0111", "FDA", "FDA-2020-D-1137", "Guidance Documents Related to Coronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2022-01-21T05:00:00Z", 2022, 1, "2022-01-21T05:00:00Z", null, "2022-04-25T03:47:44Z", "2022-01146", 0, 0, "0900006484f2cfeb"], ["FDA-2020-D-1137-0112", "FDA", "FDA-2020-D-1137", "Policy for Certain REMS Requirements During the Tocilizumab Shortage Related to the COVID-19 Public Health Emergency; Guidance for Industry and Health Care Professionals", "Other", "Guidance", "2022-01-21T05:00:00Z", 2022, 1, "2022-01-21T05:00:00Z", null, "2024-11-07T00:36:13Z", null, 1, 0, "0900006484f2d2c6"], ["FDA-2020-D-1137-0110", "FDA", "FDA-2020-D-1137", "Policy for Certain REMS Requirements During the Tocilizumab Shortage Related to the COVID-19 Public Health Emergency", "Other", "Guidance", "2021-12-13T05:00:00Z", 2021, 12, "2021-12-13T05:00:00Z", null, "2024-11-12T23:35:10Z", null, 1, 0, "0900006484ec1526"], ["FDA-2020-D-1137-0103", "FDA", "FDA-2020-D-1137", "Guidance Documents Related to Coronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2021-07-23T04:00:00Z", 2021, 7, "2021-07-23T04:00:00Z", null, "2021-07-23T15:15:46Z", "2021-15649", 0, 0, "0900006484c0aa4d"], ["FDA-2020-D-1137-0099", "FDA", "FDA-2020-D-1137", "Emergency Use Authorization for  Vaccines to Prevent COVID-19", "Other", "Guidance", "2021-06-04T04:00:00Z", 2021, 6, "2021-06-04T04:00:00Z", null, "2022-04-25T03:46:42Z", null, 0, 0, "0900006484b56371"], ["FDA-2020-D-1137-0098", "FDA", "FDA-2020-D-1137", "Emergency Use Authorization for  Vaccines to Prevent COVID-19", "Other", "Guidance", "2021-06-04T04:00:00Z", 2021, 6, "2021-06-04T04:00:00Z", null, "2022-04-25T03:46:23Z", null, 0, 0, "0900006484b5633e"], ["FDA-2020-D-1137-0090", "FDA", "FDA-2020-D-1137", "Guidance Documents Related to  Coronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2021-04-26T04:00:00Z", 2021, 4, "2021-04-26T04:00:00Z", null, "2024-11-06T23:46:14Z", "86 FR 21744", 1, 0, "0900006484ab6bda"], ["FDA-2020-D-1137-0086", "FDA", "FDA-2020-D-1137", "Good Manufacturing Practice Considerations for Responding to COVID-19 Infection in Employees in Drug and Biological Products Manufacturing - Guidance for Industry - June 2020", "Supporting & Related Material", "Background Material", "2021-02-22T05:00:00Z", 2021, 2, null, null, "2021-02-22T16:33:35Z", null, 0, 0, "0900006484a46b7c"], ["FDA-2020-D-1137-0087", "FDA", "FDA-2020-D-1137", "TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes", "Supporting & Related Material", "Background Material", "2021-02-22T05:00:00Z", 2021, 2, null, null, "2021-02-22T20:34:48Z", null, 0, 0, "0900006484a46e11"], ["FDA-2020-D-1137-0085", "FDA", "FDA-2020-D-1137", "Nelfinavir inhibits replication of severe acute respiratory syndrome coronavirus 2 in vitro", "Supporting & Related Material", "Background Material", "2021-02-22T05:00:00Z", 2021, 2, null, null, "2021-02-22T16:30:39Z", null, 0, 0, "0900006484a46b58"], ["FDA-2020-D-1137-0083", "FDA", "FDA-2020-D-1137", "Manufacturing Considerations for Licensed and Investigational Cellular and Gene Therapy Products During COVID-19 Public Health Emergency\nGuidance for Industry", "Other", "Guidance", "2021-02-09T05:00:00Z", 2021, 2, "2021-02-09T05:00:00Z", "2023-05-12T03:59:59Z", "2023-05-11T20:53:06Z", null, 0, 0, "0900006484a23d3a"], ["FDA-2020-D-1137-0060", "FDA", "FDA-2020-D-1137", "Guidance Documents Related to Coronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2020-11-18T05:00:00Z", 2020, 11, "2020-11-18T05:00:00Z", null, "2021-04-03T01:00:48Z", "2020-25399", 0, 0, "0900006484966237"], ["FDA-2020-D-1137-0049", "FDA", "FDA-2020-D-1137", "Reference 15 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:08:24Z", null, 0, 0, "0900006484946de1"], ["FDA-2020-D-1137-0053", "FDA", "FDA-2020-D-1137", "Reference 19 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:08:58Z", null, 0, 0, "0900006484946de9"], ["FDA-2020-D-1137-0041", "FDA", "FDA-2020-D-1137", "Reference 6 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:07:23Z", null, 0, 0, "0900006484946dd9"], ["FDA-2020-D-1137-0038", "FDA", "FDA-2020-D-1137", "Reference 2 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:07:00Z", null, 0, 0, "09000064849467af"], ["FDA-2020-D-1137-0043", "FDA", "FDA-2020-D-1137", "Reference 8 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:07:38Z", null, 0, 0, "0900006484946ddb"], ["FDA-2020-D-1137-0044", "FDA", "FDA-2020-D-1137", "Reference 9 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:07:45Z", null, 0, 0, "0900006484946ddc"], ["FDA-2020-D-1137-0052", "FDA", "FDA-2020-D-1137", "Reference 18 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:08:51Z", null, 0, 0, "0900006484946de8"], ["FDA-2020-D-1137-0047", "FDA", "FDA-2020-D-1137", "Reference 13 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:08:09Z", null, 0, 0, "0900006484946ddf"], ["FDA-2020-D-1137-0057", "FDA", "FDA-2020-D-1137", "Reference 23 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:09:30Z", null, 0, 0, "0900006484946ded"], ["FDA-2020-D-1137-0040", "FDA", "FDA-2020-D-1137", "Reference 4 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:07:16Z", null, 0, 0, "0900006484946dd8"], ["FDA-2020-D-1137-0048", "FDA", "FDA-2020-D-1137", "Reference 14 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:08:16Z", null, 0, 0, "0900006484946de0"], ["FDA-2020-D-1137-0039", "FDA", "FDA-2020-D-1137", "Reference 3 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:07:07Z", null, 0, 0, "09000064849467b0"], ["FDA-2020-D-1137-0050", "FDA", "FDA-2020-D-1137", "Reference 16 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:08:31Z", null, 0, 0, "0900006484946de6"], ["FDA-2020-D-1137-0046", "FDA", "FDA-2020-D-1137", "Reference 12 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:08:00Z", null, 0, 0, "0900006484946dde"], ["FDA-2020-D-1137-0055", "FDA", "FDA-2020-D-1137", "Reference 21 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:09:15Z", null, 0, 0, "0900006484946deb"], ["FDA-2020-D-1137-0037", "FDA", "FDA-2020-D-1137", "Reference 1 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:06:53Z", null, 0, 0, "09000064849467ae"], ["FDA-2020-D-1137-0051", "FDA", "FDA-2020-D-1137", "Reference 17 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:08:38Z", null, 0, 0, "0900006484946de7"], ["FDA-2020-D-1137-0042", "FDA", "FDA-2020-D-1137", "Reference 7 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:07:29Z", null, 0, 0, "0900006484946dda"], ["FDA-2020-D-1137-0056", "FDA", "FDA-2020-D-1137", "Reference 22 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:09:23Z", null, 0, 0, "0900006484946dec"], ["FDA-2020-D-1137-0045", "FDA", "FDA-2020-D-1137", "Reference 10 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:07:53Z", null, 0, 0, "0900006484946ddd"], ["FDA-2020-D-1137-0054", "FDA", "FDA-2020-D-1137", "Reference 20 re Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-11-02T05:00:00Z", 2020, 11, null, null, "2020-11-02T20:09:05Z", null, 0, 0, "0900006484946dea"], ["FDA-2020-D-1137-0036", "FDA", "FDA-2020-D-1137", "Development and Licensure of Vaccines to Prevent COVID-19; Guidance for Industry", "Other", "Guidance", "2020-11-02T05:00:00Z", 2020, 11, "2020-11-02T05:00:00Z", null, "2023-10-20T20:52:16Z", null, 0, 0, "0900006484946dee"], ["FDA-2020-D-1137-0033", "FDA", "FDA-2020-D-1137", "Ref 7 - Arabi re Investigational COVID-19 Convalescent Plasma; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-10-30T04:00:00Z", 2020, 10, null, null, "2020-10-30T16:27:18Z", null, 0, 0, "090000648486b9c9"], ["FDA-2020-D-1137-0028", "FDA", "FDA-2020-D-1137", "Ref 4 - Duan re Investigational COVID-19 Convalescent Plasma; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-10-30T04:00:00Z", 2020, 10, null, null, "2020-10-30T16:27:15Z", null, 0, 0, "090000648486b873"], ["FDA-2020-D-1137-0034", "FDA", "FDA-2020-D-1137", "Ref 6 - Leider re Investigational COVID-19 Convalescent Plasma; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-10-30T04:00:00Z", 2020, 10, null, null, "2020-10-30T16:27:19Z", null, 0, 0, "090000648486b9c8"], ["FDA-2020-D-1137-0029", "FDA", "FDA-2020-D-1137", "Ref 3 - Chen re Investigational COVID-19 Convalescent Plasma; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-10-30T04:00:00Z", 2020, 10, null, null, "2020-10-30T16:27:16Z", null, 0, 0, "090000648486b872"], ["FDA-2020-D-1137-0035", "FDA", "FDA-2020-D-1137", "Ref 5 - Cheng re Investigational COVID-19 Convalescent Plasma; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-10-30T04:00:00Z", 2020, 10, null, null, "2020-10-30T16:27:19Z", null, 0, 0, "090000648486b9c7"], ["FDA-2020-D-1137-0031", "FDA", "FDA-2020-D-1137", "Ref 1 - Roback re Investigational COVID-19 Convalescent Plasma; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-10-30T04:00:00Z", 2020, 10, null, null, "2020-10-30T16:27:17Z", null, 0, 0, "090000648486b870"], ["FDA-2020-D-1137-0030", "FDA", "FDA-2020-D-1137", "Ref 2 - Shen re Investigational COVID-19 Convalescent Plasma; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-10-30T04:00:00Z", 2020, 10, null, null, "2020-10-30T16:27:16Z", null, 0, 0, "090000648486b871"], ["FDA-2020-D-1137-0032", "FDA", "FDA-2020-D-1137", "REFERENCES LIST re Investigational COVID-19 Convalescent Plasma; Guidance for Industry", "Supporting & Related Material", "Background Material", "2020-10-30T04:00:00Z", 2020, 10, null, null, "2020-10-30T16:27:18Z", null, 0, 0, "090000648486b86f"], ["FDA-2020-D-1137-0017", "FDA", "FDA-2020-D-1137", "Investigational COVID\u201319 Convalescent Plasma; Guidance for Industry; Withdrawal of Guidance; Correction", "Notice", "Correction", "2020-10-07T04:00:00Z", 2020, 10, "2020-10-07T04:00:00Z", null, "2021-02-09T19:31:29Z", "2020-22142", 0, 0, "09000064848e55db"], ["FDA-2020-D-1137-0019", "FDA", "FDA-2020-D-1137", "Emergency Use Authorization for Vaccines to Prevent COVID-19 - Guidance for Industry  - October 2020", "Other", "Guidance", "2020-10-06T04:00:00Z", 2020, 10, "2020-10-09T04:00:00Z", null, "2025-06-15T09:00:19Z", null, 1, 0, "09000064848efd71"], ["FDA-2020-D-1137-0018", "FDA", "FDA-2020-D-1137", "Investigational COVID-19 Convalescent Plasma; Guidance for Industry - FINAL", "Other", "Guidance", "2020-09-21T04:00:00Z", 2020, 9, "2020-10-08T04:00:00Z", null, "2024-11-06T23:39:54Z", null, 1, 0, "090000648486b9b9"], ["FDA-2020-D-1137-0011", "FDA", "FDA-2020-D-1137", "Guidance Documents Related to Coronavirus Disease 2019; Availability", "Notice", "Notice of Availability", "2020-08-03T04:00:00Z", 2020, 8, "2020-08-03T04:00:00Z", null, "2021-02-09T19:31:14Z", "2020-16852", 0, 0, "09000064847ccc08"], ["FDA-2020-D-1137-0008", "FDA", "FDA-2020-D-1137", "Guidance Documents Related to Coronavirus Disease 2019 (COVID\u201319);\nAvailability", "Notice", "Notice of Availability", "2020-05-26T04:00:00Z", 2020, 5, "2020-05-26T04:00:00Z", null, "2021-02-09T19:30:57Z", "2020-11238", 0, 0, "09000064846ac689"], ["FDA-2020-D-1137-0007", "FDA", "FDA-2020-D-1137", "Guidance Documents Related to Coronavirus Disease 2019 (COVID\u201319);\nAvailability", "Notice", "Notice of Availability", "2020-05-12T04:00:00Z", 2020, 5, "2020-05-12T04:00:00Z", null, "2021-02-09T19:30:39Z", "2020-10146", 0, 0, "09000064845cd128"], ["FDA-2020-D-1137-0002", "FDA", "FDA-2020-D-1137", "Alternative Procedures for Blood and Blood Components During the COVID-19 Public Health Emergency Guidance for Industry", "Other", "Guidance", "2020-04-03T04:00:00Z", 2020, 4, "2020-04-03T04:00:00Z", null, "2024-11-06T23:35:19Z", null, 1, 0, "090000648448551c"], ["FDA-2020-D-1137-0001", "FDA", "FDA-2020-D-1137", "NOA - Process for Making Available Guidance Documents Related to Coronavirus Disease 2019", "Notice", "Announcement", "2020-03-25T04:00:00Z", 2020, 3, "2020-03-25T04:00:00Z", null, "2020-09-18T22:29:39Z", "2020-06222", 0, 0, "0900006484466342"]], "truncated": false, "filtered_table_rows_count": 55, "expanded_columns": [], "expandable_columns": [[{"column": "docket_id", "other_table": "dockets", "other_column": "id"}, "title"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "units": {}, "query": {"sql": "select id, agency_id, docket_id, title, document_type, subtype, posted_date, posted_year, posted_month, comment_start_date, comment_end_date, last_modified, fr_doc_num, open_for_comment, withdrawn, object_id from documents where \"docket_id\" = :p0 order by posted_date desc limit 101", "params": {"p0": "FDA-2020-D-1137"}}, "facet_results": {"agency_id": {"name": "agency_id", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2020-D-1137", "results": [{"value": "FDA", "label": "FDA", "count": 55, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&agency_id=FDA", "selected": false}], "truncated": false}, "document_type": {"name": "document_type", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2020-D-1137", "results": [{"value": "Supporting & Related Material", "label": "Supporting & Related Material", "count": 32, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&document_type=Supporting+%26+Related+Material", "selected": false}, {"value": "Notice", "label": "Notice", "count": 12, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&document_type=Notice", "selected": false}, {"value": "Other", "label": "Other", "count": 11, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&document_type=Other", "selected": false}], "truncated": false}, "posted_year": {"name": "posted_year", "type": "column", "hideable": false, "toggle_url": "/openregs/documents.json?docket_id=FDA-2020-D-1137", "results": [{"value": 2020, "label": 2020, "count": 39, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&posted_year=2020", "selected": false}, {"value": 2021, "label": 2021, "count": 9, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&posted_year=2021", "selected": false}, {"value": 2022, "label": 2022, "count": 4, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&posted_year=2022", "selected": false}, {"value": 2023, "label": 2023, "count": 3, "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&posted_year=2023", "selected": false}], "truncated": false}}, "suggested_facets": [{"name": "subtype", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&_facet=subtype"}, {"name": "posted_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&_facet=posted_date"}, {"name": "posted_month", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&_facet=posted_month"}, {"name": "comment_start_date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&_facet=comment_start_date"}, {"name": "open_for_comment", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&_facet=open_for_comment"}, {"name": "posted_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&_facet_date=posted_date"}, {"name": "comment_start_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&_facet_date=comment_start_date"}, {"name": "comment_end_date", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&_facet_date=comment_end_date"}, {"name": "last_modified", "type": "date", "toggle_url": "https://www.pawtectors.org/openregs/documents.json?docket_id=FDA-2020-D-1137&_facet_date=last_modified"}], "next": null, "next_url": null, "private": false, "allow_execute_sql": true, "query_ms": 1953.1909739598632, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}